High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay

Acta Medica Okayama

Volumn 63, Issue 5, 2009, Pages 249-262

  Wake, Hidenori ^a   Mori, Shuji ^b   Liu, Keyue ^a   Takahashi, Hideo K ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Heparin; HMGB1

Indexed keywords

COLLAGEN; CYTOKINE; HEPARIN; HIGH MOBILITY GROUP B1 PROTEIN; LAMININ; MATRIGEL; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLASMIN; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; C57BL MOUSE; DRUG COMBINATION; DRUG EFFECT; GENETICS; IMPLANT; MALE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; COLLAGEN; CYTOKINES; DRUG COMBINATIONS; FIBRINOLYSIN; HEPARIN; HMGB1 PROTEIN; IMPLANTS, EXPERIMENTAL; LAMININ; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 70350174004     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Colville-Nash PR and Scott DL: Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992)51: 919-925.
2. Folkman J and Shing Y: Angiogenesis. J Biol Chem (1992) 267: 10931-10934.
3. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev (2004) 56: 549-580.
4. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol (1999) 19: 5237-5246.
5. Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 418: 191-195.
6. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A and Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 285: 248-251.
7. Wang H, Yang H, Czura CJ, Sama AE and Tracey KJ: HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med (2001) 164: 1768-1773.
8. Yuan F, Gu L, Guo S, Wang C and Li GM: Evidence for involvement of HMGB1 protein in human DNA mismatch repair. J Biol Chem (2004) 279: 20935-20940.
9. Yotov WV and St-Arnaud R: Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1). Nucleic Acids Res (1992) 20: 3516.
10. Walker JM, Gooderham K, Hastings JR, Mayes E and Johns EW: The primary structures of non-histone chromosomal proteins HMG 1 and 2. FEBS Lett (1980) 122: 264-270.
11. Yamada S and Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta (2007) 375: 36-42.
12. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ and Rauvala H: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res (2002) 62: 4805-4811.
13. Karlsson S, Pettilä V, Tenhunen J, Laru-Sompa R, Hynninen M and Ruokonen E: HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Med (2008) 34: 1046-1053.
14. Porto A, Palumbo R, Pieroni M, Aprigliano G, Chiesa R, Sanvito F, Maseri A and Bianchi ME: Smooth muscle cells in human athero sclerotic plaques secrete and proliferate in response to high mobil ity group box 1 protein. FASEB J (2006) 20: 2565-2566.
15. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S and Maruyama I: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum (2003) 48: 971-981.
16. Kuniyasu H, Sasaki T, Sasahira T, Ohmori H and Takahashi T: Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer. Pathobiology (2004) 71: 129-136.
17. Kuniyasu H, Chihara Y and Kondo H: Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer (2003) 104: 722-727.
18. Kawahara N, Tanaka T, Yokomizo A, Nanri H, Ono M, Wada M, Kohno K, Takenaka K, Sugimachi K and Kuwano M: Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. Cancer Res (1996) 56: 5330-5333.
19. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM and Schmidt AM: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 405: 354-360.
20. Choi YR, Kim H, Kang HJ, Kim NG, Kim JJ, Park KS, Paik YK, Kim HO and Kim H: Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res (2003)63: 2188-2193.
21. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL and Fink MP: HMGB1 B box increases the permeability of Caco-2 entero-cytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 123: 790-802.
22. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ and Abraham E: Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol (2003) 284: C870-879.
23. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ and Yang H: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 26: 174-179.
24. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H and Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med (2000) 192: 565-570.
25. Schlueter C, Weber H, Meyer B, Rogalla P, Röser K, Hauke S and Bullerdiek J: Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol (2005) 166: 1259-1263.
26. Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E and Presta M: Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol (2006) 176: 12-15.
27. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW and Martin GR: Basement membrane complexes with biological activity. Biochemistry (1986) 25: 312-318.
28. Liu K, Mori S, Takahashi HK, Tomono Y, Wake H, Kanke T, Sato Y, Hiraga N, Adachi N, Yoshino T and Nishibori M: Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J (2007) 21: 3904-3916.
29. Li J, Wang H, Mason JM, Levine J, Yu M, Ulloa L, Czura CJ, Tracey KJ and Yang H: Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods (2004) 289: 211-223.
30. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 227: 680-685.
31. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 76: 4350-4354.
32. Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, Cossu G and Bianchi ME: Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol (2004) 164: 441-449.
33. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS and Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest (1992) 67: 519-528.
34. Isaji M, Miyata H, Ajisawa Y, Takehana Y and Yoshimura N: Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol (1997) 122: 1061-1066.
35. Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander EO, Baumann M and Rauvala H: Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem (1993) 268: 19726-19738.
36. Salmivirta M, Rauvala H, Elenius K and Jalkanen M: Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res (1992) 200: 444-451.
37. Milev P, Chiba A, Häring M, Rauvala H, Schachner M, Ranscht B, Margolis RK and Margolis RU: High affinity binding and overlap ping localization of neurocan and phosphacan/protein-tyrosine phosphatase-ζ/β with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule. J Biol Chem (1998) 273: 6998-7005.
38. Rauvala H, Huttunen HJ, Fages C, Kaksonen M, Kinnunen T, Imai S, Raulo E and Kilpeläinen I: Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol (2000) 19: 377-387.
39. van Beijnum JR, Buurman WA and Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis (2008) 11: 91-99.
40. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V and Nuseir N: Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature (1987) 329: 630-632.
41. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H and Kuwano M: Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 17: 4015-4023.
42. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G and Camussi G: Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med (1994) 180: 377-382.
43. Hiromatsu Y and Toda S: Mast cells and angiogenesis. Microsc Res Tech (2003) 60: 64-69.
44. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I and Ilan N: Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem (2004) 279: 23536-23541.
45. Cohen-Mazor M, Sela S, Mazor R, Ilan N, Vlodavsky I, Rops AL, van der Vlag J, Cohen HI and Kristal B: Are primed polymorpho-nuclear leukocytes contributors to the high heparanase levels in hemodialysis patients? Am J Physiol Heart Circ Physiol (2008) 294: H651-658
46. Yoshii M, Jikuhara A, Mori S, Iwagaki H, Takahashi HK, Nishibori M and Tanaka N: Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. J Pharmacol Sci (2005) 98: 450-458.
47. Halin S, Rudolfsson SH, Van Rooijen N and Bergh A: Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. Neoplasia (2009) 11: 177-186.